heart failure - Nursing Case Study

Pathophysiology

• Primary mechanism: Reduced cardiac output - Heart failure commonly occurs when the heart's ability to pump blood is compromised, often due to weakened heart muscle or structural abnormalities, leading to insufficient blood flow to meet the body's needs.

• Secondary mechanism: Compensatory mechanisms - In response to decreased cardiac output, the body activates the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS), causing vasoconstriction and fluid retention. While initially supportive, these compensations increase cardiac workload and worsen heart failure over time.

• Key complication: Fluid overload - As compensatory mechanisms persist, fluid retention leads to pulmonary congestion and peripheral edema, exacerbating symptoms such as shortness of breath and fatigue, and increasing the risk of hospitalization.

Patient Profile

Demographics:

62-year-old male, retired construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Chronic Obstructive Pulmonary Disease (COPD)

• Current medications: Lisinopril, Metformin, Simvastatin, Albuterol inhaler

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing shortness of breath and swelling in the legs

• Key symptoms: Fatigue, orthopnea, paroxysmal nocturnal dyspnea, weight gain

• Vital signs: Blood pressure 150/95 mmHg, heart rate 105 bpm, respiratory rate 24 breaths per minute, oxygen saturation 92% on room air, temperature 98.6°F

Section 1

During the initial assessment, the nursing team observes that the patient is experiencing increased respiratory distress, with audible crackles upon auscultation of the lung bases, indicating worsening pulmonary congestion. His jugular venous pressure is elevated, suggesting right-sided heart failure. The patient reports sleeping upright in a recliner to alleviate his orthopnea. Peripheral edema is noted in both legs, extending to the knees, with pitting present upon palpation. His skin appears cool and clammy, and he demonstrates mild cyanosis of the lips and fingertips, highlighting compromised oxygenation.

In review of the patient's laboratory results, there is an elevation in B-type Natriuretic Peptide (BNP), which is a marker for heart failure exacerbation, and mild renal impairment is evident, as indicated by increased blood urea nitrogen (BUN) and creatinine levels. Electrolyte imbalances are present, with hypokalemia noted, potentially secondary to diuretic therapy. These findings suggest that the compensatory mechanisms are failing, and the patient's renal function is being affected by decreased cardiac output and poor perfusion, necessitating careful monitoring and adjustments in medication.

Given these clinical findings, the healthcare team considers optimizing the patient’s medical management. An increase in diuretic therapy is contemplated to address fluid overload, while monitoring electrolytes closely to prevent further imbalances. The need for advanced interventions, such as non-invasive ventilation or adjustment of heart failure-specific medications, is evaluated to improve cardiac function and respiratory status. This evolving picture stresses the importance of interdisciplinary collaboration and vigilant reassessment, anticipating further developments in the patient's condition.

Section 2

As the healthcare team implements increased diuretic therapy to manage the patient’s fluid overload, they maintain close monitoring of the patient’s vital signs and laboratory values. Over the next 24 hours, the patient initially shows a reduction in peripheral edema, with decreased pitting noted upon palpation. However, despite these improvements, the patient begins to exhibit signs of hemodynamic instability. His blood pressure decreases to 88/54 mmHg, and heart rate increases to 112 beats per minute, indicating possible hypovolemia or electrolyte disturbances secondary to aggressive diuresis. The patient reports feeling dizzy and experiences episodes of near syncope when attempting to stand, suggesting orthostatic hypotension.

Laboratory results reveal a further drop in potassium levels to 3.0 mEq/L, exacerbating the hypokalemia, and a slight increase in creatinine, indicating potential acute kidney injury from the intensified diuretic regimen. The patient's electrolyte imbalances and renal function are now critical considerations in his treatment plan. The healthcare team decides to adjust the diuretic dosage and initiate potassium supplementation to address the hypokalemia. Additionally, they consider the use of an inotropic agent to support cardiac output and improve hemodynamic status, while also evaluating the need for renal function monitoring through frequent serum creatinine and urine output assessments.

This shift in the patient’s condition necessitates a multidisciplinary approach to care, involving cardiology and nephrology consultations to refine his management plan. The team discusses the possibility of initiating non-invasive positive pressure ventilation to alleviate respiratory distress and optimize oxygenation. As these interventions are put into place, the focus remains on stabilizing the patient's cardiovascular and renal status, while preventing further complications that may arise from the delicate balance of treating heart failure exacerbation with concurrent renal impairment.

Section 3

As the healthcare team implements the adjusted treatment plan, the patient's response to interventions over the next 48 hours is closely monitored. The potassium supplementation is initiated with an intravenous infusion to quickly correct the hypokalemia, while oral potassium is planned for maintenance once stable levels are achieved. The patient's potassium levels gradually increase, reaching 3.5 mEq/L, which is an encouraging sign. However, there is a new development in the patient's respiratory status. Despite the initial improvement with reduced peripheral edema, the patient reports increased shortness of breath and is visibly tachypneic with a respiratory rate of 28 breaths per minute. Arterial blood gases reveal a pH of 7.32, pCO2 of 48 mmHg, and pO2 of 60 mmHg, indicating respiratory acidosis.

In response to these findings, the healthcare team initiates non-invasive positive pressure ventilation (NIPPV) to improve oxygenation and support the patient's respiratory efforts. The patient shows some improvement in oxygen saturation, which rises from 88% to 93% on this intervention. Meanwhile, continuous cardiac monitoring reveals persistent tachycardia with frequent ectopic beats, raising concerns about potential arrhythmias due to electrolyte imbalances. A 12-lead ECG is ordered, showing occasional premature ventricular contractions (PVCs), but no significant arrhythmias are detected at this time.

The nephrology consultant recommends close monitoring of renal function, as the patient's creatinine level has stabilized but remains elevated at 1.8 mg/dL. Urine output is adequate at 30 mL/hour, suggesting some renal recovery, yet indicating the need for cautious fluid management. The cardiology team advises on the potential use of an inotropic agent; however, they recommend optimizing volume status and correcting electrolyte imbalances as the first line of action. The plan includes reassessment of the patient's hemodynamic status and a repeat of laboratory tests in the next 12 hours to evaluate the effectiveness of the current interventions and guide further treatment adjustments.

Section 4

Over the next 12 hours, the healthcare team continues to closely monitor the patient, who remains on non-invasive positive pressure ventilation. Although the patient's oxygen saturation stabilizes at 93%, there is a noticeable change in the patient's neurological status. The patient becomes increasingly lethargic and difficult to arouse, prompting a thorough neurological assessment. The Glasgow Coma Scale score has decreased to 13, with particular deficits noted in verbal response. The team is concerned about the potential contribution of hypercapnia to the patient's altered mental status, given the patient's prior arterial blood gas results indicating respiratory acidosis.

New laboratory results reveal a slight worsening of the patient's electrolyte status, with potassium levels now at 3.2 mEq/L and magnesium levels at 1.5 mg/dL, highlighting the need for further electrolyte repletion. The patient's blood urea nitrogen (BUN) has increased to 28 mg/dL, and creatinine remains stable at 1.8 mg/dL, indicating persistent renal insufficiency. In addition, a chest X-ray is obtained to assess for potential pulmonary complications, revealing mild bilateral pleural effusions and increased interstitial markings suggestive of pulmonary congestion, which may be exacerbating the patient's respiratory difficulties.

In response to these findings, the healthcare team decides to adjust the treatment plan by intensifying the electrolyte replacement strategy, including intravenous magnesium supplementation, and implementing diuretic therapy to manage the fluid overload more aggressively. A low-dose inotropic agent is reconsidered to support cardiac output, with careful monitoring for arrhythmias. The patient is reassessed frequently, focusing on neurological status, respiratory effort, and urine output, to ensure that the interventions are effective and to identify any further complications that may arise.

Section 5

As the healthcare team implements the revised treatment plan, they observe the patient's response closely. Over the next few hours, the patient's urine output increases, suggesting that the intensified diuretic therapy is effectively managing fluid overload. However, the patient's neurological status remains concerning. Despite electrolyte repletion, the patient continues to exhibit lethargy, with a Glasgow Coma Scale score unchanged at 13. Vital signs reveal a blood pressure of 105/65 mmHg, heart rate of 98 beats per minute, respiratory rate of 22 breaths per minute, and an oxygen saturation of 94% on non-invasive ventilation. These findings prompt the team to consider additional factors contributing to the patient's altered mental status.

A repeat arterial blood gas analysis is performed, revealing persistent hypercapnia with a pCO2 of 58 mmHg and a continued respiratory acidosis, albeit slightly improved from previous results. Given these findings, the team deliberates whether further adjustments to the ventilation settings might be necessary to enhance carbon dioxide clearance. Meanwhile, the patient's potassium and magnesium levels are rechecked, showing slight improvement at 3.4 mEq/L and 1.7 mg/dL, respectively, indicating that the electrolyte replacement is beginning to take effect. However, the patient’s BUN has risen further to 32 mg/dL, suggesting ongoing renal stress or dehydration secondary to diuretic therapy.

The healthcare team decides to proceed with a cautious titration of the non-invasive ventilation parameters, aiming to optimize ventilation without compromising hemodynamics. Concurrently, they initiate plans for a nephrology consultation to explore potential renal support strategies. Frequent reassessments are performed, with a focus on monitoring for any signs of electrolyte imbalances, arrhythmias, or further respiratory compromise. This vigilant approach ensures timely identification and management of any new complications, guiding the next steps in the patient’s evolving clinical journey.